title: How to handle mycophenolate mofetil in combination with tacrolimus?
authors.affiliation: Klinik für Transplantationschirurgie, George-August-Universität, Göttingen, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Braun
authors.forename: R
authors.initials: R
authors.lastname: Canelo
authors.forename: E
authors.initials: E
authors.lastname: Schütz
authors.forename: M
authors.initials: M
authors.lastname: Shipkora
authors.forename: T
authors.initials: T
authors.lastname: Lorf
authors.forename: U
authors.initials: U
authors.lastname: Hanack
authors.forename: D
authors.initials: D
authors.lastname: Niedmann
authors.forename: V W
authors.initials: VW
authors.lastname: Armstrong
authors.forename: M
authors.initials: M
authors.lastname: Oellerich
authors.forename: B
authors.initials: B
authors.lastname: Ringe
mesh_terms: D002851:Chromatography, High Pressure Liquid; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus